John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Xencor
XNCR
$2.16B
| $1.43M | ﹤0.01% |
52,219
-46,128
| -47% | -$1.14M |
|
|
HLVX
1352
DELISTED
HilleVax
HLVX
| $1.42M | ﹤0.01% |
+130,000
| New | +$1.54M |
|
1353
Mativ Holdings
MATV
$676M
| $1.42M | ﹤0.01% |
56,561
+35,753
| +172% | +$945K |
|
1354
American Homes 4 Rent
AMH
$12.5B
| $1.42M | ﹤0.01% |
39,948
-85,267
| -68% | -$3.23M |
|
1355
Information Services Group
III
$241M
| $1.41M | ﹤0.01% |
209,106
-14,286
| -6% | -$89.9K |
|
|
DCH
1356
Dauch Corp
DCH
$1.53B
| $1.41M | ﹤0.01% |
187,355
-435,155
| -70% | -$3.27M |
|
|
INBX
1357
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.41M | ﹤0.01% |
124,225
+66,452
| +115% | +$978K |
|
1358
World Kinect Corp
WKC
$1.82B
| $1.41M | ﹤0.01% |
68,747
+49,356
| +255% | +$1.21M |
|
|
RXDX
1359
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.41M | ﹤0.01% |
+49,758
| New | +$1.44M |
|
1360
Luxfer Holdings
LXFR
$458M
| $1.4M | ﹤0.01% |
92,770
-5,083
| -5% | -$82.3K |
|
|
ADVM
1361
DELISTED
Adverum Biotechnologies
ADVM
| $1.4M | ﹤0.01% |
116,456
-40,404
| -26% | -$423K |
|
1362
Forrester Research
FORR
$228M
| $1.4M | ﹤0.01% |
29,192
-7,680
| -21% | -$398K |
|
1363
Factset
FDS
$10.9B
| $1.39M | ﹤0.01% |
3,625
-7,858
| -68% | -$3.08M |
|
1364
iShares Russell 1000 ETF
IWB
$48.8B
| $1.39M | ﹤0.01% |
+6,700
| New | +$1.51M |
|
1365
1st Source
SRCE
$2.07B
| $1.39M | ﹤0.01% |
30,599
+14,600
| +91% | +$659K |
|
1366
BioAtla
BCAB
$5.46M
| $1.38M | ﹤0.01% |
9,705
-1,644
| -14% | -$262K |
|
1367
BridgeBio Pharma
BBIO
$15.8B
| $1.37M | ﹤0.01% |
151,263
-358,285
| -70% | -$3M |
|
1368
FVCBankcorp
FVCB
$334M
| $1.37M | ﹤0.01% |
91,166
+50,363
| +123% | +$806K |
|
1369
Smartbird Inc
BIRD
$28.5M
| $1.37M | ﹤0.01% |
17,433
-2,812
| -14% | -$284K |
|
|
PCSB
1370
DELISTED
PCSB Financial Corporation
PCSB
| $1.37M | ﹤0.01% |
71,609
+48,191
| +206% | +$908K |
|
|
DHC
1371
Diversified Healthcare Trust
DHC
$1.94B
| $1.37M | ﹤0.01% |
750,554
-924,182
| -55% | -$2.11M |
|
1372
Armstrong World Industries
AWI
$7.53B
| $1.36M | ﹤0.01% |
18,168
-73,087
| -80% | -$6.18M |
|
1373
DHI Group
DHX
$183M
| $1.36M | ﹤0.01% |
273,772
+154,531
| +130% | +$918K |
|
|
AZEK
1374
DELISTED
The AZEK Co
AZEK
| $1.36M | ﹤0.01% |
+81,140
| New | +$1.67M |
|
1375
NovaGold Resources
NG
$4.1B
| $1.36M | ﹤0.01% |
281,834
+176,338
| +167% | +$1.1M |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.